The dopamine agonist apomorphine enhances conditioned pain modulation in healthy humans

Neuroscience Letters

Volumn 548, Issue , 2013, Pages 115-119

  Treister, Roi ^a,b,c   Pud, Dorit ^a   Eisenberg, Elon ^b,c  

^a UNIVERSITY OF HAIFA   (Israel)

^b Institute of Pain Medicine   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Apomorphine; Conditioned pain modulation (CPM); Dopamine; Endogenous analgesia; Experimental pain

Indexed keywords

APOMORPHINE; DOPAMINE; PLACEBO;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CONDITIONED PAIN MODULATION; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DOUBLE BLIND PROCEDURE; FEMALE; HEAT SENSATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

APOMORPHINE; CONDITIONED PAIN MODULATION (CPM); DOPAMINE; ENDOGENOUS ANALGESIA; EXPERIMENTAL PAIN;

ADOLESCENT; ADULT; APOMORPHINE; CONDITIONING (PSYCHOLOGY); DOPAMINE; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; HUMANS; PAIN MEASUREMENT; PAIN PERCEPTION; PAIN THRESHOLD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880132022     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.05.041     Document Type: Article

References (26)

1. Altier N., Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 1999, 65:2269-2287.
2. Benarroch E.E. Descending monoaminergic pain modulation: bidirectional control and clinical relevance. Neurology 2008, 71:217-221.
3. Bromberg-Martin E.S., Matsumoto M., Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010, 68:815-834.
4. Cervenka S., Pålhagen S.E., Comley R.A., Panagiotidis G., Cselényi Z., Matthews J.C., Lai R.Y., Halldin C., Farde L. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 2006, 129:2017-2028.
5. Dickey R.P., Minton J.P. Levodopa relief of bone pain from breast cancer. N. Engl. J. Med. 1972, 286:843.
6. Ertas M., Sagduyu A., Arac N., Uludag B., Ertekin C. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 1988, 75:257-259.
7. Fleetwood-Walker S.M., Hope P.J., Mitchell R. Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurons. J. Physiol. 1988, 399:335-348.
8. Hagelberg N., Martikainen I.K., Mansikka H., Hinkka S., Någren K., Hietala J., Scheinin H., Pertovaara A. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 2002, 99:273-279.
9. Iyengar S., Webster A.A., Hemrick-Luecke S.K., Xu J.Y., Simmons R.M. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J. Pharmacol. Exp. Ther. 2004, 311:576-584.
10. Jääskeläinen S.K., Rinne J.O., Forssell H., Tenovuo O., Kaasinen V., Sonninen P., Bergman J. Role of the dopaminergic system in chronic pain a fluorodopa-PET study. Pain 2001, 90:257-260.
11. Kernbaum S., Hauchecorne J. Administration of levodopa for relief of herpes zoster pain. J. Am. Med. Assoc. 1981, 246:132-134.
12. Le Bars D., Dickenson A.H., Besson J.M. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 1979, 6:283-304.
13. Le Bars D. The whole body receptive field of dorsal horn multireceptive neurons. Brain Res. Brain Res. Rev. 2002, 40:29-44.
14. Lee M.A., Walker R.W., Hildreth T.J., Prentice W.M. A survey of pain in idiopathic Parkinson's disease. J. Pain Symptom Manage. 2006, 32:462-469.
15. Lindvall O., Bjorklund A., Skagerberg G. Dopamine containing neurons in the spinal cord: anatomy and some functional aspects. Ann. Neurol. 1983, 14:255-260.
16. Nixon D.W. Letter: use of l-dopa to relieve pain from bone metastases. N. Engl. J. Med. 1975, 292:647.
17. Quiton R.L., Greenspan J.D. Sex differences in endogenous pain modulation by distracting and painful conditioning stimulation. Pain 2007, 132:S134-S149.
18. Ram K.C., Eisenberg E., Haddad M., Pud D. Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain - new perspective of opioid-induced hyperalgesia. Pain 2008, 139:431-438.
19. Ribarič S. The pharmacological properties and therapeutic use of apomorphine. Molecules 2012, 17:5289-5309.
20. Schultz W., Dayan P., Montague P.R. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
21. Schulze A., Oehler B., Urban N., Schaefer M., Hill K. Apomorphine is a bimodal modulator of TRPA1 channels. Mol. Pharmacol. 2013, 83:542-551.
22. Wood P.B., Schweinhardt P., Jaeger E., Dagher A., Hakyemez H., Rabiner E.A., Bushnell M.C., Chizh B.A. Fibromyalgia patients show an abnormal dopamine response to pain. Eur. J. Neurosci. 2007, 25:3576-3582.
23. Wood P.B. Role of central dopamine in pain and analgesia. Expert Rev. Neurother. 2008, 8:781-797.
24. Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr. Opin. Anaesthesiol. 2010, 23:611-615.
25. Yarnitsky D., Arendt-Nielsen L., Bouhassira D., Edwards R.R., Fillingim R.B., Granot M., Hansson P., Lautenbacher S., Marchand S., Wilder-Smith O. Recommendations on terminology and practice of psychophysical DNIC testing. Eur. J. Pain 2010, 14:339.
26. Yarnitsky D., Granot M., Nahman-Averbuch H., Khamaisi M., Granovsky Y. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 2012, 153:1193-1198.